XML 153 R135.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Plans (Summary of Restricted Stock and Stock Option Activity) (Detail)
12 Months Ended
Dec. 31, 2020
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted Stock, Granted (in shares) 0
Restricted stock, Outstanding at end of period (in shares) 250,666
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options granted, Number of Shares 266,325
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 0
Options exercised, Number of Shares 10,230
Options outstanding, at end of period, Number of Shares 410,701
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Options vested, Weighted-Average Exercise Price (in dollars per share) | $ / shares $ 0
Options, at end of period, Weighted-average Exercise Price (in dollars per share) | $ / shares $ 23.35
Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock, Outstanding at beginning of period (in shares) 450,224
Restricted Stock, Granted (in shares) 296,435
Restricted stock, Vested restricted stock awards (in shares) 171,852
Restricted stock, Forfeited (in shares) 27,622
Restricted stock, Outstanding at end of period (in shares) 547,185
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock, at beginning of period, Weighted-average Grant Date Fair Value (in dollars per share) | $ / shares $ 54.53
Restricted stock, Granted (in dollars per share) | $ / shares 37.79
Restricted stock, Vested restricted stock awards (in dollars per share) | $ / shares 52.22
Restricted stock, Forfeited (in dollars per share) | $ / shares 45.98
Restricted stock, at end of period, Weighted-average Grant Date Fair Value (in dollars per share) | $ / shares $ 46.59
Performance Shares [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock, Outstanding at beginning of period (in shares) 233,304
Restricted Stock, Granted (in shares) 106,739
Restricted stock, Vested restricted stock awards (in shares) 79,836
Restricted stock, Forfeited (in shares) 9,541
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock, at beginning of period, Weighted-average Grant Date Fair Value (in dollars per share) | $ / shares $ 54.94
Restricted stock, Granted (in dollars per share) | $ / shares 40.56
Restricted stock, Vested restricted stock awards (in dollars per share) | $ / shares 56.18
Restricted stock, Forfeited (in dollars per share) | $ / shares 50.42
Restricted stock, at end of period, Weighted-average Grant Date Fair Value (in dollars per share) | $ / shares $ 48.77
Share-based Payment Arrangement, Option [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Options outstanding, at beginning of period, Number of Shares 420,931
Options granted, Number of Shares 0
Options forfeited, Number of Shares 0
Options exercised, Number of Shares 10,230
Options outstanding, at end of period, Number of Shares 410,701
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Options, at beginning of period, Weighted-average Exercise Price (in dollars per share) | $ / shares $ 23.35
Options granted, Weighted-Average Exercise Price (in dollars per share) | $ / shares 0
Options forfeited, Weighted-Average Exercise Price (in dollars per share) | $ / shares 0
Options exercised, Weighted-Average Exercise Price (in dollars per share) | $ / shares 23.51
Options, at end of period, Weighted-average Exercise Price (in dollars per share) | $ / shares $ 23.35